Botulinum Toxin (BOTOX) for Stomach Cancer Treatment
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Change of tumor volume in the stomach.
Change measured with a standardized CT protocol (Thickness of the stomach wall and diameter of the tumor).
Baseline and 8 weeks
No
Jon Erik Grønbech, MD. PhD.
Principal Investigator
St Olavs Hospital Trondheim University Hospital
Norway: Norwegian Medicines Agency
StOlav2205
NCT01822210
January 2013
February 2016
Name | Location |
---|